English
Bulgarian
Chinese (Simplified)
Croatian
Czech
Danish
Dutch
Finnish
French
German
Greek
Hebrew
Hindi
Indonesian
Italian
Japanese
Korean
Macedonian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swedish
Thai
Turkish
Vietnamese
News
Recognising those improving CML treatment in Low and Middle Income Countries - the 2023 iCMLf Prize nominees
April 2023 - The iCMLf Prize honours people who have done outstanding work improving CML management under resource-constraint conditions in low and middle-income countries. Each year, we receive many nominations from the CML community for this prize…
And it’s always difficult to make a choice...
This year the iCMLf prize was awarded to Professor Iryna Dyagil and Dr Kostyantyn Kotlyarchuk, two Ukrainian hematologists in recognition of their work for people with CML under the challenging conditions of war and disruption.
In addition, there were also 11 physicians and patient advocates from ten different countries who were nominated for their dedication and life changing work for people with CML.
Today we are taking the opportunity to acknowledge all of the nominees and to thank them for their work to help people with CML in low and middle-income countries – through their research, their clinical practice and through their advocacy.
New program announcement - Regional Discussions on CML
With the mission to improve outcomes for people with CML globally, a core part of the role of the iCMLf is to ensure best practice treatment for people with CML around the world. Since 2010 our programs throughout low- and middle-income countries have expanded access to CML education, networks, and discussions - all of which have improved the way CML is managed. In 2023 we are delighted to announce a new program – iCMLf Regional Discussions on CML.
The 2023 iCMLf Rowley Prize is awarded to Professor Jerry Radich
March 2023 - The iCMLf is delighted to announce that Professor Jerry Radich, Director of the Radich Laboratory and the Molecular Oncology Laboratory at the Fred Hutchinson Cancer Center in Seattle (USA), is the winner of the 2023 Rowley Prize. The iCMLf Rowley Prize is awarded to celebrate people who have made outstanding lifetime contributions to the understanding of the biology of CML.
“I am honored and humbled by receiving the Rowley Prize. To be included in the company of past winners, under the name of the miraculous Janet Rowley, strains my belief and comprehension. I cannot adequately enough thank those who have given me this award, and those in my lab who have actually done the work.” (Professor Jerry Radich)
The 2023 Goldman Prize is awarded to Professor François Guilhot
March 2023 - Professor François Guilhot, an Emeritus Professor of Hematology and the past Director of the Clinical Investigation Center, 1402 INSERM in Poitiers, France, will receive the 2023 iCMLf Goldman Prize. Professor Guilhot receives the award in recognition of his pioneering achievements in important clinical trials in CML and his longstanding leadership in the management of CML. The annual Goldman Prize, awarded in honour of Professor John Goldman, acknowledges outstanding lifetime contributions to the management of patients with CML.
"Many great scientists have already received the John Goldman Prize. And I am very honoured to have been selected this year;this award recognizes 35 years of research and care for CML patients.” (Professor François Guilhot)
The 2023 iCMLf Prize is awarded to two Ukrainian hematologists - Kostyantyn Kotlyarchuk & Iryna Dyagil
March 2023 - The iCMLf Prize in 2023 recognizes the work of Ukrainian hematologists in this time of war and disruption. The iCMLf Directors and Advisors have chosen the two nominated Ukrainian hematologists to jointly accept this prize in 2023:
- Professor Iryna Dyagil
Head of the Department of Radiation Oncohematology, National Scientific Center for Radiation Medicine of the National Academy of Medical Sciences of Ukraine,
Kyiv (Ukraine) - Dr Kostyantyn Kotlyarchuk
Head of the Hematology Department SI ‘Institute of Blood Pathology and Transfusion Medicine NAMS’, Lviv (Ukraine)
The iCMLf Prize recognizes outstanding contributions to the improvement of CML under the challenging conditions of low- and middle-income countries with unequal access to monitoring and access.
iCMLf Conversation: Genomics and Mutations in CML – Assessment and Risk
You're invited to our next iCMLf Conversation on March 30th at 1.30 CEST!
March 2023 - We are delighted to share that Professor Susan Branford from SA Pathology in Adelaide will be the CML expert for our next iCMLf Conversation on Thursday, March 30 th at 1.30 pm Central European Summer Time. Join us for this live expert talk on Zoom to hear her talking about genomics and mutations in CML. Professor Branford will share her expertise on mutation assessment and significance in CML and will discuss the concept of genomically-based risk assessment in CML.
